[1]李芳 唐江萍** 姜丽 曹云桂 程明军 张宇雨.诺舒子宫内膜去除术治疗伴有严重内科合并症的异常子宫出血[J].中国微创外科杂志,2020,01(11):1000-1004.
　Li Fang,Tang Jiangping,Jiang Li,et al.NovaSure Endometrium Removal in the Treatment of Abnormal Uterine Bleeding With Severe Medical Complications[J].Chinese Journal of Minimally Invasive Surgery,2020,01(11):1000-1004.
点击复制

诺舒子宫内膜去除术治疗伴有严重内科合并症的异常子宫出血()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2020年11期
页码:
1000-1004
栏目:
临床研究
出版日期:
2020-11-25

文章信息/Info

Title:
NovaSure Endometrium Removal in the Treatment of Abnormal Uterine Bleeding With Severe Medical Complications
作者:
李芳 唐江萍** 姜丽 曹云桂 程明军 张宇雨
（上海市嘉定区妇幼保健院妇科，上海201821）
Author(s):
Li Fang;  Tang Jiangping;  Jiang Li;  et al.
Department of Gynaecology, Shanghai Jiading District Maternal and Child Health Hospital, Shanghai 201821, China
关键词:
第二代子宫内膜去除术;  诺舒;  异常子宫出血; 内科合并症
Keywords:
Secondgeneration endometrial ablation; NovaSure; Abnormal uterine bleeding; Medical complication
文献标志码:
A
摘要:
目的探讨诺舒（NovaSure）治疗伴有严重内科合并症的异常子宫出血的安全性和有效性。方法回顾性分析2011年5月~2019年7月诺舒治疗异常子宫出血90例资料，其中合并严重内科疾病31例（A组），未合并严重内科疾病59例（B组）。比较2组围术期指标及术后闭经率、有效率、手术满意率。结果90例均顺利完成手术，其中B组2例术后1个月切除子宫（1例因子宫内膜不典型增生，1例术后出血行宫腔镜电切时子宫穿孔）。随访88例，术后6、12、24、36、48、60个月闭经率70.4%~72.6%，有效率94.4%~97.0%，手术满意率95.7%~97.7%。术后3个月，血红蛋白由术前（99.7±211）g/L升高至（111.6±10.2）g/L（P<0.05），子宫内膜厚度由术前（7.6±2.9）mm降低至（4.8±0.8）mm（P<0.05）。A、B组手术时间、术后并发症、再次手术率以及术后半年的闭经率、有效率、手术满意率差异均无显著性(P>0.05)。结论诺舒子宫内膜去除术治疗异常子宫出血安全、有效、可行，同样适用于合并严重内科疾病者。
Abstract:
ObjectiveTo investigate the safety and efficacy of NovaSure in the treatment of abnormal uterine bleeding with severe medical complications.MethodsThe data of 90 cases of abnormal uterine bleeding treated with NovaSure from May 2011 to July 2019 were retrospectively analyzed. Among them, 31 cases were complicated with serious medical diseases (group A), and there were 59 cases without serious medical diseases (group B). The perioperative indexes, postoperative amenorrhea rate, effective rate and satisfaction rate were compared between the two groups.ResultsThe operations were successfully completed in all the 90 patients. Two patients in the group B underwent hysterectomy 1 month after operation (1 case because of endometrial dysplasia, and another due to uterine perforation during hysteroscopy). The rate of amenorrhea was 70.4%-72.6% in 88 cases who were followed at 6, 12, 24, 36, 48, and 60 months after operation. The effective rate was 94.4%-97.0%, and the surgical satisfaction rate was 95.7%-97.7%. Three months after surgery, the hemoglobin was increased from (99.7±21.1) g/L before surgery to (111.6±10.2) g/L (P<0.05). The endometrial thickness was decreased from (7.6±2.9) mm to (4.8±0.8) mm (P<0.05). There were no statistically significant differences between the two groups in operation time, postoperative complications, reoperation rate, amenorrhea rate, effective rate and operation satisfaction rate six months after operation (P>0.05).ConclusionsNovaSure endometrial removal is safe, effective and feasible for the treatment of abnormal uterine bleeding. It is also applicable to patients with severe medical diseases.

参考文献/References:

[1]Spencer JC，Louie M，Moulder JK，et al．Costeffectiveness of treatments for heavy menstrual bleeding．Am J Obstet Gynecol，2017，217(5):574．
[2]冯力民,边茜.诺舒阻抗控制子宫内膜切除术的临床应用现状.武警医学,2016,27（6）:541-544.
[3]韦利英,赵仁峰,李雪,等.诺舒阻抗子宫内膜切除系统治疗月经过多151例分析.中国妇产科临床杂志,2016,17（2）:132-135.
[4]段华.子宫内膜去除术治疗月经过多的现状与评价.实用妇产科杂志,2006,22(6)：321-323.
[5]冯缵冲，邵敬於.实用宫腔镜学.上海：上海医科大学出版社，1999.104.
[6]陈丽梅，郭罗培，张宏伟，等.双极射频子宫内膜去除术治疗异常子宫出血的前瞻性、多中心临床对照研究.实用妇产科杂志，2018，34（10）：750-754.
[7]Louie M，Spencer J，Wheeler S，et al．Comparison of the levonorgestrelreleasing intrauterine system，hysterectomy，and endometrial ablation for heavy menstrual bleeding in a decision analysis model．Int J Gynaecol Obstet，2017，139(2):121-129．
[8]Cozza G，Pinto A，Giovanale V，et al．Comparative effectiveness and impact on healthrelated quality of life of hysterectomy vs．levonorgestrel intrauterine system for abnormal uterine bleeding．Eur Rev Med Pharmacol Sci，2017，21(9):2255-2260．
[9]Gimpelson RJ．Tenyear literature review of global endometrial ablation with the NovaSure device．Int J Womens Health，2014，3(6):269-280．
[10]Herman MC，van den Brink MJ，Geomini PM，et al．Levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation (Novasure) in women with heavy menstrual bleeding:a multicenter randomized controlled trial．BMC Womens Health，2013，13:32．
[11]孙小丽，赵春梅，牛静，等.204例诺舒子宫内膜去除术治疗月经过多的远期疗效.中国微创外科杂志,2019,19（7）:577-579.
[12]马宁，夏恩兰，赵玉婷，等．第二代子宫内膜去除术诺舒临床应用70例分析．国际妇产科学杂志，2014，41(5):526-530．
[13]黄伟容,吴玉英,赵仁峰.第二代子宫内膜去除术诺舒治疗尿毒症月经过多的临床分析.实用医学杂志,2015,31（18）:143-145.
[14]袁博，王武亮，邓克红，等.诺舒治疗异常子宫出血38例.中国微创外科杂志,2017,17（5）:418-421.
[15]刘青，张华，刘继娟．诺舒阻抗控制子宫内膜切除治疗肝病合并异常子宫出血30 例． 中国微创外科杂志，2014，14(4):304-307．

备注/Memo

备注/Memo:
基金项目：上海市医学重点专科(ZK2015B08)**通讯作者，Email：tangjiangping6666@163.com
更新日期/Last Update: 2021-02-07